A Stk4-Foxp3-NF-?B p65 transcriptional complex promotes Treg cell activation and homeostasis
dc.contributor.author | Cui, Ye | |
dc.contributor.author | Benamar, Mehdi | |
dc.contributor.author | Schmitz-Abe, Klaus | |
dc.contributor.author | Poondi-Krishnan, Varsha | |
dc.contributor.author | Chen, Qian | |
dc.contributor.author | Jugder, Bat-Erdene | |
dc.contributor.author | Fatou, Benoit | |
dc.date.accessioned | 2024-02-23T14:26:09Z | |
dc.date.available | 2024-02-23T14:26:09Z | |
dc.date.issued | 2022 | |
dc.department | NEÜ | en_US |
dc.description.abstract | The molecular programs involved in regulatory T (T-reg) cell activation and homeostasis remain incompletely understood. Here, we show that T cell receptor (TCR) signaling in T-reg cells induces the nuclear translocation of serine/threonine kinase 4 (Stk4), leading to the formation of an Stk4-NF-kappa B p65-Foxp3 complex that regulates Foxp3- and p65-dependent transcriptional programs. This complex was stabilized by Stk4-dependent phosphorylation of Foxp3 on serine-418. Stk4 deficiency in T-reg cells, either alone or in combination with its homolog Stk3, precipitated a fatal autoimmune lymphoproliferative disease in mice characterized by decreased Treg cell p65 expression and nuclear translocation, impaired NF-kappa B p65-Foxp3 complex formation, and defective Treg cell activation. In an adoptive immunotherapy model, overexpression of p65 or the phosphomimetic Foxp3S418E in Stk3/4-deficient T-reg cells ameliorated their immune regulatory defects. Our studies identify Stk4 as an essential TCR-responsive regulator of p65-Foxp3-dependent transcription that promotes T-reg cellmediated immune tolerance. | en_US |
dc.description.sponsorship | NIH [R01AI085090, R01AI128976, R01AI153174] | en_US |
dc.description.sponsorship | This work was supported by NIH grants R01AI085090 and R01AI128976 to T.A.C. and grant R01AI153174 to L.-M.C. | en_US |
dc.identifier.doi | 10.1126/sciimmunol.abl8357 | |
dc.identifier.issn | 2470-9468 | |
dc.identifier.issue | 75 | en_US |
dc.identifier.pmid | 36149942 | en_US |
dc.identifier.scopus | 2-s2.0-85138458537 | en_US |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.uri | https://doi.org/10.1126/sciimmunol.abl8357 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12452/14072 | |
dc.identifier.volume | 7 | en_US |
dc.identifier.wos | WOS:000933998800005 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Amer Assoc Advancement Science | en_US |
dc.relation.ispartof | Science Immunology | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | [Keyword Not Available] | en_US |
dc.title | A Stk4-Foxp3-NF-?B p65 transcriptional complex promotes Treg cell activation and homeostasis | en_US |
dc.type | Article | en_US |